You are here: Industry Insights > virus

News List

COVID-19 vaccine stirs rare hesitation in nearly virus-free Singapore expresspharma
December 23, 2020
The first shipment of the Pfizer-BioNTech vaccine arrived this week and Singapore expects to have enough vaccines for all 5.7 million people by the third quarter of 2021.
Pharmacovigilance during a pandemic expresspharma
December 10, 2020
As coronavirus has become the new reality for every health worker and life science company to fight in the front, it is time to relook the approach being taken by the industry towards pharmacovigilance.
Boehringer Ingelheim to acquire Labor Dr Merk & Kollegen expresspharma
December 10, 2020
Transaction expands Boehringer Ingelheim’s R&D and clinical manufacturing capabilities with a site focused predominantly on ATMP-based cancer immunology treatments.
Prebona proves unique, long-term effect against COVID-19/SARS CoV-2 prnasia
November 06, 2020
Independent test-institutes have confirmed that Prebona Disinfect is extremely effective against the coronavirus - SARS CoV-2, COVID-19.
Equine polyclonal antibodies have shown higher potency in in-vitro studies of SARS-CoV-2 virus neutralisation expresspharma
November 05, 2020
Bharat Serums and Vaccines has initiated a research project to co-develop an equine polyclonal antibody, alongwith NIV, against COVID-19.
Piramal Pharma’s consumer division launches Tri-Activ disinfectant spray for COVID-19 expresspharma
October 29, 2020
The company claims that for multi-surfaces it is “99.9 per cent effective against the COVID-19 virus in one minute.
Beroni Group Announces Successful Completion of SARS-CoV-2 Pseudovirus Neutralization Assay americanpharmaceuticalreview
October 26, 2020
Beroni Group has announced successful completion of SARS-CoV-2 pseudovirus neutralization assay in collaboration with GenScript Biotech Corporation. The assay targets on coronavirus-specific nanobodies and tests affinity and efficacy to prevent the ...
Potential COVID-19 vaccines not affected by dominant "G-Strain" worldpharmanews
October 14, 2020
Vaccines currently being developed for COVID-19 should not be affected by recent mutations in the virus, according to a new study involving a University of York virologist.
Bacterial viperins prove effective against human viruses: Researchers expresspharma
September 27, 2020
The molecules produced by the bacterial viperins are currently undergoing testing against human viruses such as the influenza virus and COVID-19.
Contact tracing inside infected cells offer new clues about SARS-CoV-2 virus: Study expresspharma
September 23, 2020
The findings of this research could lead to better diagnostics or new treatments, as well as helping to explain what makes this virus so good at the process of infection.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page